ChangT.M.S.: Haemoperfusions over microencapsulated adsorbent in a patient with hepatic coma.Lancetii, 1371, 1972.
2.
ChiritoE., ReiterB., ListerC., ChangT.M.S.: Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.Artif. Organs1(1), 76, 1977.
3.
ChangT.M.S., ListerC., ChiritoE., O'KeefeP., ResurreccionE.: Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.Trans. Amer. Soc. Artif. Intern. Organs24, 243, 1978.
4.
TabataY., ChangT.M.S.: Comparisons of six artificial liver support regimens in fulminant hepatic coma rats.Trans. Amer. Soc. Artif. Intern. Organs26, 394, 1980.
5.
StachuraJ., TarnawskiA., SzczudrawaJ., BogdalJ., MachT., KlinczykB., KirchmayerS.: Cytoprotective effect of 16,16 Dimethyl prostaglandin E2 and some drugs on an acute galactosamine induced liver damage rat.Folia Histochem. Cytochem.9, 311, 1980.
